A Phase 2/3, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of GX-19N, A COVID-19 Preventive DNA Vaccine in Healthy Individuals

Tahapan Penelitian : Complete
Sponsor:
Mitra Pelaksana:
not specified
No Registry
INA-5L15LDW
Tanggal Input Registry : 19-07-2024

01-01-2021
not specified
 
A Phase 2/3, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of GX-19N, A COVID-19 Preventive DNA Vaccine in Healthy Individuals
A Phase 2/3, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of GX-19N, A COVID-19 Preventive DNA Vaccine in Healthy Individuals
Interventional
GX-19N, A COVID-19 Preventive DNA Vaccine
5
 

Inclusion Criteria:

not specified

Exclusion Criteria:

not specified
 
not specified
Not applicable
PPUK/PPUB number
not specified